Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > ARGENTA DISCOVERY 2009 LIMITED
Company Information for

ARGENTA DISCOVERY 2009 LIMITED

Robinson Building Chesterford Research Park, Little Chesterford, Saffron Walden, CB10 1XL,
Company Registration Number
06920289
Private Limited Company
Active - Proposal to Strike off

Company Overview

About Argenta Discovery 2009 Ltd
ARGENTA DISCOVERY 2009 LIMITED was founded on 2009-06-01 and has its registered office in Saffron Walden. The organisation's status is listed as "Active - Proposal to Strike off". Argenta Discovery 2009 Limited is a Private Limited Company registered in ENGLAND with Companies House and the accounts submission requirement is categorised as DORMANT
  • Company is not active ie not engaged in any business activity or receiving income or profits
  • Is not incurring costs other than: Annual return fee, late filing fees, companies house admin fees eg company name change or share payments
  • Holds no assets capable of producing any profits or income
  • Holds assets that are unlikely to produce profits and income in the near future
  • Investment trusts, pensions and client account companies may show as dormant companies as they are non trading
Key Data
Company Name
ARGENTA DISCOVERY 2009 LIMITED
 
Legal Registered Office
Robinson Building Chesterford Research Park
Little Chesterford
Saffron Walden
CB10 1XL
Other companies in CT9
 
Previous Names
CONTINENTAL SHELF 468 LIMITED08/07/2009
Filing Information
Company Number 06920289
Company ID Number 06920289
Date formed 2009-06-01
Country ENGLAND
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active - Proposal to Strike off
Lastest accounts 2021-12-25
Account next due 30/09/2023
Latest return 01/06/2016
Return next due 29/06/2017
Type of accounts DORMANT
VAT Number /Sales tax ID GB977473757  
Last Datalog update: 2023-03-08 03:49:54
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for ARGENTA DISCOVERY 2009 LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of ARGENTA DISCOVERY 2009 LIMITED

Current Directors
Officer Role Date Appointed
SARAH MARGARET PRICE
Company Secretary 2014-05-28
BIRGIT GIRSHICK
Director 2016-09-28
DAVID P JOHST
Director 2014-04-01
JACQUELINE ANNE MACRITCHIE
Director 2017-11-01
DAVID ROSS SMITH
Director 2014-11-17
Previous Officers
Officer Role Date Appointed Date Resigned
KATHERINE LOUISE HILYARD
Director 2015-09-01 2017-11-01
EMILY HICKEY
Director 2015-09-01 2016-09-23
THOMAS FRANCIS ACKERMAN
Director 2014-04-01 2015-08-31
JAMES C FOSTER
Director 2014-04-01 2015-08-31
SARAH MARGARET PRICE
Company Secretary 2014-03-07 2014-04-01
JOHN GARY MONTANA
Director 2009-09-18 2014-04-01
DAVID ROSS SMITH
Director 2014-03-07 2014-04-01
ONNO VAN DE STOLPE
Director 2010-02-01 2014-04-01
JOHAN GUSTAAF CYRIEL VAN DEN EYNDE
Company Secretary 2010-02-01 2014-01-31
CHRISTOPHER GREGORY NEWTON
Director 2010-02-01 2013-11-22
COLIN GRAHAM KNOX
Company Secretary 2009-07-07 2010-02-01
CHRISTOPHER PHILIP ASHTON
Director 2009-07-07 2010-02-01
COLIN GRAHAM KNOX
Director 2009-07-07 2010-02-01
ANTHONY GERARD MARTIN BARRETT
Director 2009-09-18 2010-01-25
HARRY FINCH
Director 2009-09-18 2010-01-25
MARY FRANCES FITZGERALD
Director 2009-09-18 2010-01-25
IAN FLETCHER KENT
Director 2009-09-18 2010-01-25
MARTIN PATRICK MURPHY
Director 2009-09-18 2010-01-25
HUGO ALEXANDER SLOOTWEG
Director 2009-09-18 2010-01-25
ALAN ROWE WILLIAMSON
Director 2009-09-18 2010-01-25
NIGEL AARON PITCHFORD
Director 2009-09-18 2009-10-15
MD SECRETARIES LIMITED
Company Secretary 2009-06-01 2009-07-07
PATRICK MARTIN
Director 2009-06-01 2009-07-07
MD DIRECTORS LIMITED
Director 2009-06-01 2009-07-07

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
BIRGIT GIRSHICK KWS BIOTEST LIMITED Director 2018-01-11 CURRENT 2003-12-01 Active
BIRGIT GIRSHICK BIOFOCUS DPI (HOLDINGS) LTD Director 2016-09-28 CURRENT 1996-09-23 Active
BIRGIT GIRSHICK CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED Director 2016-09-28 CURRENT 2002-12-19 Active
BIRGIT GIRSHICK CANGENIX LIMITED Director 2016-09-28 CURRENT 2011-04-01 Active - Proposal to Strike off
DAVID P JOHST BIOFOCUS DPI (HOLDINGS) LTD Director 2014-04-01 CURRENT 1996-09-23 Active
DAVID P JOHST CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED Director 2014-04-01 CURRENT 2002-12-19 Active
DAVID P JOHST CHARLES RIVER U.K. LIMITED Director 2007-03-12 CURRENT 1969-03-18 Active
DAVID P JOHST CHARLES RIVER LABORATORIES HOLDINGS LIMITED Director 2007-03-12 CURRENT 1999-12-10 Active
JACQUELINE ANNE MACRITCHIE KWS BIOTEST LIMITED Director 2018-01-11 CURRENT 2003-12-01 Active
JACQUELINE ANNE MACRITCHIE BIOFOCUS DPI (HOLDINGS) LTD Director 2017-11-01 CURRENT 1996-09-23 Active
JACQUELINE ANNE MACRITCHIE CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED Director 2017-11-01 CURRENT 2002-12-19 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2023-03-14SECOND GAZETTE not voluntary dissolution
2022-12-27FIRST GAZETTE notice for voluntary strike-off
2022-12-27GAZ1(A)FIRST GAZETTE notice for voluntary strike-off
2022-12-15Application to strike the company off the register
2022-12-15Application to strike the company off the register
2022-12-15DS01Application to strike the company off the register
2022-10-21RES14Resolutions passed:
  • Capitalise £814,803 10/10/2022
  • Resolution of allotment of securities
2022-10-12Resolutions passed:<ul><li>Resolution reduction in capital</ul>
2022-10-12Solvency Statement dated 10/10/22
2022-10-12Statement by Directors
2022-10-12Statement of capital on GBP 0.005
2022-10-12SH19Statement of capital on 2022-10-12 GBP 0.005
2022-10-12SH20Statement by Directors
2022-10-12CAP-SSSolvency Statement dated 10/10/22
2022-10-12RES06Resolutions passed:
  • Resolution of reduction in issued share capital
2022-06-21APPOINTMENT TERMINATED, DIRECTOR DAVID ROSS SMITH
2022-06-21DIRECTOR APPOINTED MR BRENT GREETHAM
2022-06-21CONFIRMATION STATEMENT MADE ON 01/06/22, WITH NO UPDATES
2022-06-21CS01CONFIRMATION STATEMENT MADE ON 01/06/22, WITH NO UPDATES
2022-06-21AP01DIRECTOR APPOINTED MR BRENT GREETHAM
2022-06-21TM01APPOINTMENT TERMINATED, DIRECTOR DAVID ROSS SMITH
2022-03-24AAACCOUNTS FOR DORMANT COMPANY MADE UP TO 25/12/21
2021-07-05CS01CONFIRMATION STATEMENT MADE ON 01/06/21, WITH NO UPDATES
2021-03-10AAACCOUNTS FOR DORMANT COMPANY MADE UP TO 26/12/20
2020-06-16CS01CONFIRMATION STATEMENT MADE ON 01/06/20, WITH NO UPDATES
2020-05-21AP01DIRECTOR APPOINTED MISS SARAH MARGARET PRICE
2020-05-21TM01APPOINTMENT TERMINATED, DIRECTOR DAVID P JOHST
2020-02-25AAACCOUNTS FOR DORMANT COMPANY MADE UP TO 28/12/19
2019-10-10AAACCOUNTS FOR DORMANT COMPANY MADE UP TO 29/12/18
2019-06-14CS01CONFIRMATION STATEMENT MADE ON 01/06/19, WITH NO UPDATES
2018-11-05AD01REGISTERED OFFICE CHANGED ON 05/11/18 FROM Charles River Manston Road Margate Kent CT9 4LT
2018-09-05AAFULL ACCOUNTS MADE UP TO 30/12/17
2018-06-15LATEST SOC15/06/18 STATEMENT OF CAPITAL;GBP 1803184.335
2018-06-15CS01CONFIRMATION STATEMENT MADE ON 01/06/18, WITH UPDATES
2017-11-02AP01DIRECTOR APPOINTED DR JACQUELINE ANNE MACRITCHIE
2017-11-01TM01APPOINTMENT TERMINATED, DIRECTOR KATHERINE LOUISE HILYARD
2017-10-05AAFULL ACCOUNTS MADE UP TO 31/12/16
2017-08-11MEM/ARTSARTICLES OF ASSOCIATION
2017-08-11MEM/ARTSARTICLES OF ASSOCIATION
2017-06-27SH0109/06/17 STATEMENT OF CAPITAL GBP 1803184.335
2017-06-26LATEST SOC26/06/17 STATEMENT OF CAPITAL;GBP .005
2017-06-26SH19Statement of capital on 2017-06-26 GBP 0.005
2017-06-26SH20Statement by Directors
2017-06-26CAP-SSSolvency Statement dated 23/06/17
2017-06-26RES06Resolutions passed:
  • Resolution of reduction in issued share capital
2017-06-19RES14CAPITALISATION OF £1475022 09/06/2017
2017-06-19RES01ALTER ARTICLES 09/06/2017
2017-06-19RES10Resolutions passed:
  • Resolution of allotment of securities
  • Capitalisation of £1475022 09/06/2017
  • Resolution alteration of articles
2017-06-13LATEST SOC13/06/17 STATEMENT OF CAPITAL;GBP 328162.335
2017-06-13CS01CONFIRMATION STATEMENT MADE ON 01/06/17, WITH UPDATES
2016-10-06AAFULL ACCOUNTS MADE UP TO 31/12/15
2016-09-30AP01DIRECTOR APPOINTED BIRGIT GIRSHICK
2016-09-28TM01APPOINTMENT TERMINATED, DIRECTOR EMILY HICKEY
2016-06-27LATEST SOC27/06/16 STATEMENT OF CAPITAL;GBP 328162.335
2016-06-27AR0101/06/16 ANNUAL RETURN FULL LIST
2016-06-27CH01Director's details changed for Mr David Ross Smith on 2015-09-01
2015-10-13AP01DIRECTOR APPOINTED DR EMILY HICKEY
2015-10-12AP01DIRECTOR APPOINTED MS KATHERINE LOUISE HILYARD
2015-10-12TM01APPOINTMENT TERMINATED, DIRECTOR JAMES FOSTER
2015-10-12TM01APPOINTMENT TERMINATED, DIRECTOR THOMAS ACKERMAN
2015-10-09AAFULL ACCOUNTS MADE UP TO 31/12/14
2015-06-25LATEST SOC25/06/15 STATEMENT OF CAPITAL;GBP 328162.335
2015-06-25AR0101/06/15 ANNUAL RETURN FULL LIST
2014-11-24AP01DIRECTOR APPOINTED MR DAVID ROSS SMITH
2014-10-14AAFULL ACCOUNTS MADE UP TO 31/12/13
2014-10-03AP03SECRETARY APPOINTED MISS SARAH MARGARET PRICE
2014-06-13LATEST SOC13/06/14 STATEMENT OF CAPITAL;GBP 328162.335
2014-06-13AR0101/06/14 FULL LIST
2014-04-23AP01DIRECTOR APPOINTED DAVID P JOHST
2014-04-23AP01DIRECTOR APPOINTED JAMES C FOSTER
2014-04-23AP01DIRECTOR APPOINTED THOMAS FRANCIS ACKERMAN
2014-04-17AUDAUDITOR'S RESIGNATION
2014-04-17AD01REGISTERED OFFICE CHANGED ON 17/04/2014 FROM 8-9 SPIRE GREEN CENTRE FLEX MEADOW HARLOW ESSEX CM19 5TR
2014-04-17TM01APPOINTMENT TERMINATED, DIRECTOR JOHN MONTANA
2014-04-17TM01APPOINTMENT TERMINATED, DIRECTOR DAVID SMITH
2014-04-17TM01APPOINTMENT TERMINATED, DIRECTOR ONNO VAN DE STOLPE
2014-04-17TM02APPOINTMENT TERMINATED, SECRETARY SARAH PRICE
2014-03-13AP01DIRECTOR APPOINTED DAVID ROSS SMITH
2014-03-13AP03SECRETARY APPOINTED SARAH MARGARET PRICE
2014-03-13TM02APPOINTMENT TERMINATED, SECRETARY JOHAN VAN DEN EYNDE
2014-03-13TM01APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER NEWTON
2013-10-07AAFULL ACCOUNTS MADE UP TO 31/12/12
2013-07-12AR0101/06/13 FULL LIST
2012-06-06AR0101/06/12 FULL LIST
2012-04-04AAFULL ACCOUNTS MADE UP TO 31/12/11
2011-06-06AR0101/06/11 FULL LIST
2011-03-22AAFULL ACCOUNTS MADE UP TO 31/12/10
2010-10-01MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 1
2010-10-01MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 3
2010-10-01MG01PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 2
2010-09-27AAFULL ACCOUNTS MADE UP TO 31/12/09
2010-06-16AR0101/06/10 FULL LIST
2010-06-16CH01DIRECTOR'S CHANGE OF PARTICULARS / DR JOHN GARY MONTANA / 01/06/2010
2010-03-22AA01PREVSHO FROM 30/06/2010 TO 31/12/2009
2010-02-19SH10NOTICE OF PARTICULARS OF VARIATION OF RIGHTS ATTACHED TO SHARES
2010-02-19SH08NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2010-02-17AP01DIRECTOR APPOINTED CHRISTOPHER GREGORY NEWTON
2010-02-17AP01DIRECTOR APPOINTED ONNO VAN DE STOLPE
2010-02-17AP03SECRETARY APPOINTED JOHAN GUSTAAF CYRIEL VAN DEN EYNDE
2010-02-10TM02APPOINTMENT TERMINATED, SECRETARY COLIN KNOX
2010-02-10TM01APPOINTMENT TERMINATED, DIRECTOR COLIN KNOX
2010-02-10TM01APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER ASHTON
2010-01-29SH0117/09/09 STATEMENT OF CAPITAL GBP 328162.335
2010-01-28TM01APPOINTMENT TERMINATED, DIRECTOR HUGO SLOOTWEG
2010-01-28TM01APPOINTMENT TERMINATED, DIRECTOR MARTIN MURPHY
2010-01-28TM01APPOINTMENT TERMINATED, DIRECTOR IAN KENT
2010-01-28TM01APPOINTMENT TERMINATED, DIRECTOR HARRY FINCH
2010-01-28TM01APPOINTMENT TERMINATED, DIRECTOR ALAN WILLIAMSON
2010-01-28TM01APPOINTMENT TERMINATED, DIRECTOR ANTHONY BARRETT
2010-01-28TM01APPOINTMENT TERMINATED, DIRECTOR MARY FITZGERALD
2010-01-26CAP-SSSOLVENCY STATEMENT DATED 25/01/10
2010-01-26SH20STATEMENT BY DIRECTORS
2010-01-26SH1926/01/10 STATEMENT OF CAPITAL GBP 328162.335
2010-01-26RES13SHARE PREMIUM ACCOUNT BE REDUCED BY £3.75M 22/01/2010
2010-01-26RES06REDUCE ISSUED CAPITAL 22/01/2010
2010-01-26CC01NOTICE OF RESTRICTION ON THE COMPANY'S ARTICLES
2010-01-26SH02SUB-DIVISION 22/01/10
2010-01-26RES13SHARE SUB-DIVISION 22/01/2010
2010-01-26RES01ADOPT ARTICLES 22/01/2010
2010-01-26SH08NOTICE OF NAME OR OTHER DESIGNATION OF CLASS OF SHARES
2010-01-05SH0117/09/09 STATEMENT OF CAPITAL GBP 411678.69
2009-12-01MEM/ARTSARTICLES OF ASSOCIATION
2009-11-16RES01ALTER ARTICLES 30/10/2009
2009-11-09SH0117/09/09 STATEMENT OF CAPITAL GBP 411678.69
2009-11-02TM01APPOINTMENT TERMINATED, DIRECTOR NIGEL PITCHFORD
2009-10-29MISCSCHEME OF ARRANGEMENT
2009-10-26AP01DIRECTOR APPOINTED DR MARY FRANCES FITZGERALD
2009-10-26AP01DIRECTOR APPOINTED IAN FLETCHER KENT
2009-10-26AP01DIRECTOR APPOINTED DR NIGEL ARRON PITCHFORD
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to ARGENTA DISCOVERY 2009 LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against ARGENTA DISCOVERY 2009 LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 3
Mortgages/Charges outstanding 3
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
Charge Type Date of Charge Charge Status Mortgagee
RENT DEPOSIT DEED 2010-10-01 Outstanding USF NOMINEES LIMITED
RENT DEPOSIT DEED 2010-10-01 Outstanding USF NOMINEES LIMITED
RENT DEPOSIT DEED 2010-10-01 Outstanding USF NOMINEES LIMITED
Filed Financial Reports
Annual Accounts
2013-12-31
Annual Accounts
2012-12-31
Annual Accounts
2011-12-31
Annual Accounts
2010-12-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on ARGENTA DISCOVERY 2009 LIMITED

Intangible Assets
Patents
We have not found any records of ARGENTA DISCOVERY 2009 LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for ARGENTA DISCOVERY 2009 LIMITED
Trademarks

Trademark applications by ARGENTA DISCOVERY 2009 LIMITED

ARGENTA DISCOVERY 2009 LIMITED is the Original Applicant for the trademark ARGENTA ™ (WIPO1178171) through the WIPO on the 2013-06-03
Chemicals, chemical compounds and fragments used in industry and science; chemicals, chemical compounds and chemical fragments organized into libraries; all the above expressly excluding any product related to the banking or financial sector.
Produits chimiques, fragments et composés chimiques destinés à l'industrie et aux sciences; produits chimiques, composés chimiques et fragments chimiques organisés sous forme de bibliothèques; tous les produits précités excluant expressément tout produit concernant les secteurs bancaire ou financier.
Productos químicos, compuestos y fragmentos químicos para uso industrial y científico; productos químicos, compuestos y fragmentos químicos organizados en bibliotecas; ninguno de los productos mencionados guarda relación con los sectores bancario y financiero.
ARGENTA DISCOVERY 2009 LIMITED is the Original Applicant for the trademark ARGENTA ™ (79137167) through the USPTO on the 2013-06-03
Chemicals, chemical compounds and fragments used in pharmaceutical, biotechnology, and academic scientific research; chemicals, chemical compounds and chemical fragments organized into libraries for use in pharmaceutical, biotechnology, and academic scientific research; all the above expressly excluding any product related to the banking or financial sector
ARGENTA DISCOVERY 2009 LIMITED is the for the trademark ARGENTA DISCOVERY ™ (76120730) through the USPTO on the 2000-08-31
Issue New Certificate to: ARGENTA DISCOVERY 2009 LIMITED (United Kingdom PRIVATE LIMITED COMPANY) 8/9 SPIRE GREEN CENTRE, FLEX MEADOW HARLOW United Kingdom CM 19 5TR In the statement, Column 1, lines 13-14," LICENSING OF PATENTS, TRADEMARKS AND OTHER KINDS OF" is deleted. In the statement, Column 2, lines 1-3," INTELLECTUAL PROPERTY RELATING TO THE FIELDS OF PHARMACEUTICAL AND HEALTHCARE PRODUCTS" is deleted.
Income
Government Income
We have not found government income sources for ARGENTA DISCOVERY 2009 LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as ARGENTA DISCOVERY 2009 LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where ARGENTA DISCOVERY 2009 LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by ARGENTA DISCOVERY 2009 LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2015-07-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2015-07-0128
2015-07-0129321900Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
2015-07-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2015-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2015-06-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2015-06-0129420000Separate chemically defined organic compounds, n.e.s.
2015-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-06-0184798200Mixing, kneading, crushing, grinding, screening, sifting, homogenising, emulsifying or stirring machines, n.e.s. (excl. industrial robots)
2015-05-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2015-05-0129213099Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereof (excl. cyclohexylamine, cyclohexyldimethylamine and their salts, and cyclohex-1,3-ylenediamine "1,3-diaminocyclohexane")
2015-05-0129319080
2015-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-04-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2015-04-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2015-04-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2015-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-04-0184242000Spray guns and similar appliances (other than electrical machines, appliances and other devices for spraying molten metals or metal carbides of heading 8515, sand blasting machines and similar jet projecting machines)
2015-03-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2015-03-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2015-03-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2015-03-0130021010Antisera
2015-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-02-0129420000Separate chemically defined organic compounds, n.e.s.
2015-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2015-01-0129420000Separate chemically defined organic compounds, n.e.s.
2015-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-12-0129420000Separate chemically defined organic compounds, n.e.s.
2014-12-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-11-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2014-11-0129319090Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2014-11-0129420000Separate chemically defined organic compounds, n.e.s.
2014-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-11-0190278099Non-electronic instruments and apparatus for physical or chemical analysis or for determining surface tension or the like, or for measuring heat or sound, n.e.s.
2014-10-0129420000Separate chemically defined organic compounds, n.e.s.
2014-10-0130029010Human blood
2014-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-09-0129093090Aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. diphenyl ether and brominated derivatives)
2014-09-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2014-09-0129420000Separate chemically defined organic compounds, n.e.s.
2014-09-0130021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-08-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2014-08-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2014-08-0129420000Separate chemically defined organic compounds, n.e.s.
2014-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-06-0105119985Animal products, n.e.s.; dead animals, unfit for human consumption (excl. fish, crustaceans, molluscs and other aquatic invertebrates)
2014-06-0129
2014-06-0129420000Separate chemically defined organic compounds, n.e.s.
2014-06-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2014-06-0184879090Machinery parts of chapter 84, not intended for a specific purpose, n.e.s.
2014-06-0185176200Machines for the reception, conversion and transmission or regeneration of voice, images or other data, incl. switching and routing apparatus (excl. telephone sets, telephones for cellular networks or for other wireless networks)
2014-04-0124022090Cigarettes, containing tobacco (excl. containing cloves)
2014-04-0129350090Sulphonamides (excl. 3-{1-[7-"hexadecylsulphonylamino"-1H-indole-3-yl]-3-oxo-1H, 3H-naphtho[1,8-cd]pyran-1-yl}-N,N-dimethyl-1H-indole-7-sulphonamide and metosulam "ISO")
2014-04-0129420000Separate chemically defined organic compounds, n.e.s.
2014-04-0130021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-04-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2014-04-0138210000Prepared culture media for the development or maintenance of micro-organisms "incl. viruses and the like" or of plant, human or animal cells
2014-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-04-0148201050Diaries with calendars, of paper or paperboard
2014-03-0129029000Cyclic hydrocarbons (excl. cyclanes, cyclenes, benzene, toluene, xylenes, styrene, ethylbenzene and cumene)
2014-03-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2014-03-0129420000Separate chemically defined organic compounds, n.e.s.
2014-03-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2014-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-03-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2014-02-0129420000Separate chemically defined organic compounds, n.e.s.
2014-02-0130012010Extracts of glands or other organs or of their secretions, of human origin, for organo-therapeutic uses
2014-02-0130021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2014-01-0121061020Protein concentrates and textured protein substances, not containing milkfats, sucrose, isoglucose starch or glucose or containing, by weight, < 1,5% milkfat, < 5% sucrose or isoglucose, < 5% glucose or < 5% starch
2014-01-0129389090Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives (excl. rutoside "rutin" and its derivatives, digitalis glycosides, glycyrrhizic acid and glycyrrhizates)
2014-01-0129420000Separate chemically defined organic compounds, n.e.s.
2014-01-0130021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2014-01-0130029010Human blood
2014-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-12-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2013-12-0129420000Separate chemically defined organic compounds, n.e.s.
2013-12-0130021091Haemoglobin, blood globulins and serum globulins
2013-12-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-11-0128100090Oxides of boron and boric acids (excl. diboron trioxide)
2013-11-0129319090Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2013-11-0129420000Separate chemically defined organic compounds, n.e.s.
2013-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-10-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2013-09-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2013-09-0130021091Haemoglobin, blood globulins and serum globulins
2013-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-08-0129221985Amino-alcohols, their ethers and esters; salts thereof (other than those containing > one kind of oxygen function and excl. monoethanolamine, diethanolamine, triethanolamine, dextropropoxyphene "INN" and their salts, and N-ethyldiethanolamine and 2,2'-methyliminodiethanol "N-methyldiethanolamine" and 2-(N,N-Diisopropylamino)ethanol)
2013-08-0129319090Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2013-08-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2013-08-0129420000Separate chemically defined organic compounds, n.e.s.
2013-08-0130021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-08-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2013-07-0121061020Protein concentrates and textured protein substances, not containing milkfats, sucrose, isoglucose starch or glucose or containing, by weight, < 1,5% milkfat, < 5% sucrose or isoglucose, < 5% glucose or < 5% starch
2013-07-0129
2013-07-0129420000Separate chemically defined organic compounds, n.e.s.
2013-07-0130012010Extracts of glands or other organs or of their secretions, of human origin, for organo-therapeutic uses
2013-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-06-0129221985Amino-alcohols, their ethers and esters; salts thereof (other than those containing > one kind of oxygen function and excl. monoethanolamine, diethanolamine, triethanolamine, dextropropoxyphene "INN" and their salts, and N-ethyldiethanolamine and 2,2'-methyliminodiethanol "N-methyldiethanolamine" and 2-(N,N-Diisopropylamino)ethanol)
2013-06-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-06-0129420000Separate chemically defined organic compounds, n.e.s.
2013-06-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2013-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-05-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2013-05-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2013-05-0129420000Separate chemically defined organic compounds, n.e.s.
2013-05-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2013-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-04-0129420000Separate chemically defined organic compounds, n.e.s.
2013-04-0130029010Human blood
2013-04-0130045000Medicaments containing provitamins, vitamins, incl. natural concentrates and derivatives thereof used primarily as vitamins, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale
2013-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-04-0184718000Units for automatic data-processing machines (excl. processing units, input or output units and storage units)
2013-03-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2013-03-0129342080Heterocyclic compounds containing in the structure a benzothiazole ring-system, whether or not hydrogenated, but not further fused (excl. di"benzothiazol-2-yl"disulphide; benzothiazole-2-thiol "mercaptobenzothiazole" and its salts, and inorganic or organic compounds of mercury)
2013-03-0129420000Separate chemically defined organic compounds, n.e.s.
2013-03-0130021098Blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)
2013-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-02-0129182900Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. salicylic acid and o-Acetylsalicylic acid, and their salts and esters)
2013-02-0129420000Separate chemically defined organic compounds, n.e.s.
2013-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-01-0129420000Separate chemically defined organic compounds, n.e.s.
2013-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-12-0129269095Nitrile-function compounds (excl. acrylonitrile, 1-cyanoguanidine "dicyandiamide", fenproporex "INN" and its salts, methadone "INN"-intermediate "4-cyano-2-dimethylamino-4,4-diphenylbutane" and isophthalonitrile)
2012-12-0129420000Separate chemically defined organic compounds, n.e.s.
2012-12-0130021099
2012-12-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-11-0129420000Separate chemically defined organic compounds, n.e.s.
2012-11-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2012-10-0129319090Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2012-10-0129420000Separate chemically defined organic compounds, n.e.s.
2012-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-08-0129319090Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
2012-08-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2012-08-0130021099
2012-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-07-0130021099
2012-06-0129163990Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. benzoic acid, its salts and esters, benzoyl peroxide, benzoyl chloride, binapacryl [ISO], phenylacetic acid, its salts and esters, and inorganic or organic compounds of mercury whether or not chemically defined)
2012-06-0129420000Separate chemically defined organic compounds, n.e.s.
2012-06-0130019098Dried glands and other organs for organo-therapeutic uses, whether or not powdered, and other substances of animal origin prepared for therapeutic or prophylactic uses, n.e.s. (excl. heparin and its salts)
2012-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-05-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2012-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-03-0129269095Nitrile-function compounds (excl. acrylonitrile, 1-cyanoguanidine "dicyandiamide", fenproporex "INN" and its salts, methadone "INN"-intermediate "4-cyano-2-dimethylamino-4,4-diphenylbutane" and isophthalonitrile)
2012-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-02-0130021099
2012-01-0129420000Separate chemically defined organic compounds, n.e.s.
2012-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-12-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2011-12-0130021095
2011-11-0129335995Heterocyclic compounds with nitrogen hetero-atom"s" only, containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure (excl. malonylurea "barbituric acid" and its derivatives, allobarbital "INN", amobarbital "INN", barbital "INN", butalbital "INN", butobarbital "INN", cyclobarbital "INN", methylphenobarbital "INN", pentobarbital "INN", phenobarbital "INN", secbutabarbital "INN", secobarbital "INN", vinylbital "INN", loprazolam "INN", mecloqualone "INN", methaqu
2011-11-0129420000Separate chemically defined organic compounds, n.e.s.
2011-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-10-0135079030Lipoprotein lipase and aspergillus alkaline protease
2011-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-09-0130021095
2011-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-08-0129420000Separate chemically defined organic compounds, n.e.s.
2011-08-0130021099
2011-08-0135040090Peptones and their derivatives; other albuminous substances and their derivatives, n.e.s.; hide powder, whether or not chromed (excl. concentrated milk proteins with a protein content > 85 % by weight, calculated on the dry matter
2011-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-06-0129214900Aromatic monoamines and derivatives; salts thereof (excl. aniline, toluidines, diphenylamine, 1-naphthylamine "alpha-naphthylamine", 2-naphthylamine "beta-naphthylamine" and their derivatives, and salts thereof, and amfetamine "INN", benzfetamine "INN", dexamfetamine "INN", etilamfetamine "INN", fencamfamine "INN", lefetamine "INN", levamfetamine "INN", mefenorex "INN" and phentermine "INN", and salts thereof)
2011-06-0129310099
2011-06-0129350090Sulphonamides (excl. 3-{1-[7-"hexadecylsulphonylamino"-1H-indole-3-yl]-3-oxo-1H, 3H-naphtho[1,8-cd]pyran-1-yl}-N,N-dimethyl-1H-indole-7-sulphonamide and metosulam "ISO")
2011-06-0129420000Separate chemically defined organic compounds, n.e.s.
2011-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-05-0129
2011-05-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2011-04-0129310010
2011-04-0129334990Heterocyclic compounds with nitrogen hetero-atom[s] only, containing in the structure a quinoline or isoquinoline ring-system, whether or not hydrogenated, but not further fused (excl. levorphanol "INN", dextromethorphan "INN", and their salts, halogen derivatives of quinoline, quinolinecarboxylic acid derivatives, and inorganic or organic compounds of mercury)
2011-04-0129420000Separate chemically defined organic compounds, n.e.s.
2011-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-03-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2011-03-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2011-03-0129420000Separate chemically defined organic compounds, n.e.s.
2011-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-01-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2010-12-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2010-12-0129420000Separate chemically defined organic compounds, n.e.s.
2010-11-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2010-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-10-0129420000Separate chemically defined organic compounds, n.e.s.
2010-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-10-0139269097Articles of plastics and articles of other materials of heading 3901 to 3914, n.e.s.
2010-09-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2010-09-01293399502,4-Di-tert-butyl-6-"5-chlorobenzotriazol-2-yl"phenol
2010-09-0129420000Separate chemically defined organic compounds, n.e.s.
2010-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-08-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2010-08-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2010-07-0128444080Radioactive elements, isotopes and compounds (excl. subheading 2844.10, 2844.20, 2844.30 and 2844.40.10 to 2844.40.30); alloys, dispersions incl. cermets, ceramic products and mixtures containing these elements, isotopes or compounds; radioactive residues (excl. of uranium derived from U 233)
2010-06-0135
2010-05-0129331990Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyrazole ring, whether or not hydrogenated, in the structure (excl. phenazone "antipyrin" and its derivatives and phenylbutazone "INN")
2010-05-0129420000Separate chemically defined organic compounds, n.e.s.
2010-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-04-0130069200Waste pharmaceuticals
2010-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-01-0128444080Radioactive elements, isotopes and compounds (excl. subheading 2844.10, 2844.20, 2844.30 and 2844.40.10 to 2844.40.30); alloys, dispersions incl. cermets, ceramic products and mixtures containing these elements, isotopes or compounds; radioactive residues (excl. of uranium derived from U 233)
2010-01-0130021010Antisera

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded ARGENTA DISCOVERY 2009 LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded ARGENTA DISCOVERY 2009 LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.